GPP
APYX icon

Great Point Partners’s Apyx Medical APYX Stock Holding History

Great Point Partners’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,829,441
Closed -$6.18M – 41
2017
Q3 		$6.18M Sell
1,829,441
-1,094,574
-37% -$2.83M 1.2% 26
2017
Q2 		$7.22M Sell
2,924,015
-130,985
-4% -$322K 1.29% 24
2017
Q1 		$8.16M Hold
3,055,000
– – 1.62% 21
2016
Q4 		$11M Buy
3,055,000
+375,000
+14% +$1.67M 2.25% 18
2016
Q3 		$14M Hold
2,680,000
– – 3.56% 13
2016
Q2 		$4.39M Hold
2,680,000
– – 1.26% 21
2016
Q1 		$4.48M Hold
2,680,000
– – 1.61% 21
2015
Q4 		$5.63M Hold
2,680,000
– – 2.36% 16
2015
Q3 		$5.23M Hold
2,680,000
– – 2.07% 21
2015
Q2 		$7.48M Buy
2,680,000
+2,200,000
+458% +$6.05M 2.91% 12
2015
Q1 		$1.15M Buy
+480,000
New +$1.6M 0.5% 27

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Great Point Partners's APYX Position: Q4 2017 in Review

Great Point Partners sold out of Apyx Medical (APYX) in Q4 2017, closing a stake of 1,829,441 shares — an estimated $6.18M sold.

Great Point Partners first reported a position in APYX in Q1 2015 and held it in 11 quarters. The position peaked at $14M in Q3 2016. 41 funds tracked by Wall St. Rank hold APYX as of Q4 2017.

  • Great Point Partners reported no remaining Apyx Medical position as of Q4 2017 after selling out during the quarter.
  • Great Point Partners sold 1,829,441 Apyx Medical shares in Q4 2017, an estimated $6.18M.
  • Great Point Partners first reported a position in Apyx Medical in Q1 2015 and held it in 11 quarters.
  • Great Point Partners's Apyx Medical position peaked at $14M in Q3 2016.
  • 41 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2017.

Based on Great Point Partners's 13F filing for Q4 2017, filed 14 Feb 2018.